{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:17:57Z","timestamp":1792520277678,"version":"4.5.0"},"reference-count":197,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T001674\/1"],"award-info":[{"award-number":["MR\/T001674\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","award":["24CO4"],"award-info":[{"award-number":["24CO4"]}],"id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00983","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T04:46:27Z","timestamp":1590122787000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":102,"title":["Strategies in Translating the Therapeutic Potentials of Host Defense Peptides"],"prefix":"10.3389","volume":"11","author":[{"given":"Darren Shu Jeng","family":"Ting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger W.","family":"Beuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder S.","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajamani","family":"Lakshminarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol Mol Biol Rev."},{"key":"B2","unstructured":"Tackling drug-resistant infections globally: final report and recommendations\n            O'NeillJ\n          Rev Antimicrob Resist2016"},{"key":"B3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/antibiotics4040467","article-title":"Antibiotic stewardship initiatives as part of the UK 5-year antimicrobial resistance strategy","volume":"4","author":"Johnson","year":"2015","journal-title":"Antibiotics."},{"key":"B5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: an emerging category of therapeutic agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front Cell Infect Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-13-3588-4_1","article-title":"Antimicrobial peptides of multicellular organisms: my perspective","volume":"1117","author":"Zasloff","year":"2019","journal-title":"Adv Exp Med Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fchem.2019.00043","article-title":"Reassessing the host defense peptide landscape","volume":"7","author":"Haney","year":"2019","journal-title":"Front Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: the antimicrobial peptide database as a tool for research and education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucl Acids Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e66557","DOI":"10.1371\/journal.pone.0066557","article-title":"LAMP: a database linking antimicrobial peptides","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS ONE."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.03.004","article-title":"Human antimicrobial peptides in ocular surface defense","volume":"61","author":"Mohammed","year":"2017","journal-title":"Prog Retin Eye Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"AAC","DOI":"10.1128\/AAC.02340-16","article-title":"Intracellular targeting mechanisms by antimicrobial peptides","volume":"61","author":"Le","year":"2017","journal-title":"Antimicrob Agents Chemother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.3390\/ijms20194877","article-title":"Non-Lytic antibacterial peptides that translocate through bacterial membranes to act on intracellular targets","volume":"20","author":"Cardoso","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4103\/joacp.JOACP_349_15","article-title":"Action and resistance mechanisms of antibiotics: a guide for clinicians","volume":"33","author":"Kapoor","year":"2017","journal-title":"J Anaesthesiol Clin Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-981-13-3588-4_14","article-title":"AMPs as anti-biofilm agents for human therapy and prophylaxis","volume":"1117","author":"Shahrour","year":"2019","journal-title":"Adv Exp Med Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3402\/ehtj.v2i0.7078","article-title":"Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections","volume":"2","author":"Nijnik","year":"2009","journal-title":"Emerg Health Threats J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/exd.12929","article-title":"Antimicrobial peptides and wound healing: biological and therapeutic considerations","volume":"25","author":"Mangoni","year":"2016","journal-title":"Exp Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"46635","DOI":"10.18632\/oncotarget.16743","article-title":"Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications","volume":"8","author":"Deslouches","year":"2017","journal-title":"Oncotarget."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.2174\/0929867326666190805151654","article-title":"Antiviral activities of human host defense peptides","volume":"27","author":"Brice","year":"2020","journal-title":"Curr Med Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s41433-018-0085-4","article-title":"A 10-year analysis of microbiological profiles of microbial keratitis: the North East England study","volume":"32","author":"Ting","year":"2018","journal-title":"Eye."},{"key":"B20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.survophthal.2018.12.003","article-title":"The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance","volume":"64","author":"Ung","year":"2019","journal-title":"Surv Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1097\/ICL.0000000000000517","article-title":"Polymicrobial keratitis with cryptococcus curvatus, candida parapsilosis, and Stenotrophomonas maltophilia after penetrating keratoplasty: a rare case report with literature review","volume":"45","author":"Ting","year":"2019","journal-title":"Eye Contact Lens."},{"key":"B22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat Rev Drug Discov."},{"key":"B23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnins.2017.00073","article-title":"Membrane active antimicrobial peptides: translating mechanistic insights to design","volume":"11","author":"Li","year":"2017","journal-title":"Front Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd3591","article-title":"Designing antimicrobial peptides: form follows function","volume":"11","author":"Fjell","year":"2011","journal-title":"Nat Rev Drug Discov."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat Biotechnol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"j4339","DOI":"10.1136\/bmj.j4339","article-title":"Few novel antibiotics in the pipeline, WHO warns","volume":"358","author":"Kmietowicz","year":"2017","journal-title":"BMJ."},{"key":"B27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/molecules23020311","article-title":"The road from host-defense peptides to a new generation of antimicrobial drugs","volume":"23","author":"Boto","year":"2018","journal-title":"Molecules."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.2174\/0929867324666170815102441","article-title":"Antimicrobial peptides: a promising therapeutic strategy in tackling antimicrobial resistance","volume":"24","author":"Nuti","year":"2017","journal-title":"Curr Med Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2174\/138161212799277617","article-title":"Therapeutic potential of host defense peptides in antibiotic-resistant infections","volume":"18","author":"Afacan","year":"2012","journal-title":"Curr Pharm Des."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-6737-7_1","article-title":"Antimicrobial peptides: an introduction","volume":"1548","author":"Haney","year":"2017","journal-title":"Methods Mol Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/bip.22250","article-title":"Peptide design for antimicrobial and immunomodulatory applications","volume":"100","author":"Haney","year":"2013","journal-title":"Biopolymers."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3389\/fmicb.2019.02866","article-title":"Mechanisms of action for antimicrobial peptides with antibacterial and antibiofilm functions","volume":"10","author":"Raheem","year":"2019","journal-title":"Front Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1039\/C1MB05297G","article-title":"More effective antimicrobial mastoparan derivatives, generated by 3D-QSAR-Almond and computational mutagenesis","volume":"8","author":"Avram","year":"2012","journal-title":"Mol Biosyst."},{"key":"B34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/1471-2105-8-263","article-title":"Analysis and prediction of antibacterial peptides","volume":"8","author":"Lata","year":"2007","journal-title":"BMC Bioinformatics."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.bbamem.2015.12.013","article-title":"Improving short antimicrobial peptides despite elusive rules for activity","volume":"1858","author":"Mikut","year":"2016","journal-title":"Biochim Biophys Acta."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s00253-019-09698-y","article-title":"Melittin: from honeybees to superbugs","volume":"103","author":"Memariani","year":"2019","journal-title":"Appl Microbiol Biotechnol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0167-4838(93)90024-L","article-title":"Influence of tryptophan residues on melittin's hemolytic activity","volume":"1202","author":"Blondelle","year":"1993","journal-title":"Biochim Biophys Acta."},{"key":"B38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1126\/science.2237415","article-title":"A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids","volume":"250","author":"O'Neil","year":"1990","journal-title":"Science."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1073\/pnas.89.13.5937","article-title":"Side-chain entropy opposes alpha-helix formation but rationalizes experimentally determined helix-forming propensities","volume":"89","author":"Creamer","year":"1992","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e67597","DOI":"10.1371\/journal.pone.0067597","article-title":"A proline-hinge alters the characteristics of the amphipathic alpha-helical AMPs","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS ONE."},{"key":"B41","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/19439","article-title":"Antibacterial peptide from H. pylori","volume":"398","author":"Putsep","year":"1999","journal-title":"Nature."},{"key":"B42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3389\/fchem.2019.00753","article-title":"Quantitation of a novel engineered anti-infective host defense peptide, ARV-1502: pharmacokinetic study of different doses in rats and dogs","volume":"7","author":"Brakel","year":"2019","journal-title":"Front Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1021\/jm100378b","article-title":"Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens","volume":"53","author":"Knappe","year":"2010","journal-title":"J Med Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/cmdc.201900465","article-title":"Proline-rich peptides with improved antimicrobial activity against E. coli, K. pneumoniae, and A. baumannii","volume":"14","author":"Mardirossian","year":"2019","journal-title":"ChemMedChem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/cmdc.201800734","article-title":"Search for shorter portions of the proline-rich antimicrobial peptide fragment Bac5(1-25) that retain antimicrobial activity by blocking protein synthesis","volume":"14","author":"Mardirossian","year":"2019","journal-title":"ChemMedChem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e00534","DOI":"10.1128\/AAC.00534-18","article-title":"Fragments of the nonlytic proline-rich antimicrobial peptide Bac5 kill Escherichia coli cells by inhibiting protein synthesis","volume":"62","author":"Mardirossian","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1039\/C7NP00020K","article-title":"Proline-rich antimicrobial peptides targeting protein synthesis","volume":"34","author":"Graf","year":"2017","journal-title":"Nat Prod Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1128\/AAC.00490-06","article-title":"Enhanced membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH","volume":"50","author":"Mason","year":"2006","journal-title":"Antimicrob Agents Chemother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1074\/jbc.M806201200","article-title":"Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides","volume":"284","author":"Mason","year":"2009","journal-title":"J Biol Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e47047","DOI":"10.1371\/journal.pone.0047047","article-title":"Structural and functional characterization of a multifunctional alanine-rich peptide analogue from Pleuronectes americanus","volume":"7","author":"Migliolo","year":"2012","journal-title":"PLoS ONE."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1128\/AAC.02218-12","article-title":"Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens","volume":"57","author":"Deslouches","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/molecules23040815","article-title":"Tryptophan-rich and proline-rich antimicrobial peptides","volume":"23","author":"Mishra","year":"2018","journal-title":"Molecules."},{"key":"B53","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1073\/pnas.84.15.5449","article-title":"Magainins, a class of antimicrobial peptides from xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor","volume":"84","author":"Zasloff","year":"1987","journal-title":"Proc Natl Acad Sci USA."},{"key":"B54","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1073\/pnas.85.3.910","article-title":"Antimicrobial activity of synthetic magainin peptides and several analogues","volume":"85","author":"Zasloff","year":"1988","journal-title":"Proc Natl Acad Sci USA."},{"key":"B55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00894-015-2622-4","article-title":"Analysis of the flexibility and stability of the structure of magainin in a bilayer, and in aqueous and nonaqueous solutions using molecular dynamics simulations","volume":"21","author":"Esmaili","year":"2015","journal-title":"J Mol Model."},{"key":"B56","doi-asserted-by":"publisher","first-page":"12358","DOI":"10.1021\/jp904154w","article-title":"Molecular interactions between magainin 2 and model membranes in situ","volume":"113","author":"Nguyen","year":"2009","journal-title":"J Phys Chem B."},{"key":"B57","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1073\/pnas.86.17.6597","article-title":"Magainins and the disruption of membrane-linked free-energy transduction","volume":"86","author":"Westerhoff","year":"1989","journal-title":"Proc Natl Acad Sci USA."},{"key":"B58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/bip.360370206","article-title":"Structure-activity studies on magainins and other host defense peptides","volume":"37","author":"Maloy","year":"1995","journal-title":"Biopolymers."},{"key":"B59","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/0014-5793(88)80077-2","article-title":"Synthetic magainin analogues with improved antimicrobial activity","volume":"236","author":"Chen","year":"1988","journal-title":"FEBS Lett."},{"key":"B60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0005-2736(97)00051-5","article-title":"Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria","volume":"1327","author":"Matsuzaki","year":"1997","journal-title":"Biochim Biophys Acta."},{"key":"B61","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/prot.20152","article-title":"The occurrence of C\u2013H.O hydrogen bonds in alpha-helices and helix termini in globular proteins","volume":"56","author":"Manikandan","year":"2004","journal-title":"Proteins."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.bbamem.2008.10.009","article-title":"Structure, membrane orientation, mechanism, and function of pexiganan\u2013a highly potent antimicrobial peptide designed from magainin","volume":"1788","author":"Gottler","year":"2009","journal-title":"Biochim Biophys Acta."},{"key":"B63","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1128\/AAC.43.4.782","article-title":"In vitro antibacterial properties of pexiganan, an analog of magainin","volume":"43","author":"Ge","year":"1999","journal-title":"Antimicrob Agents Chemother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2165\/00003495-199856060-00011","article-title":"Pexiganan acetate","volume":"56","author":"Lamb","year":"1998","journal-title":"Drugs."},{"key":"B65","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/antibiotics8040193","article-title":"Diabetic foot ulcers: current advances in antimicrobial therapies and emerging treatments","volume":"8","author":"Ramirez-Acuna","year":"2019","journal-title":"Antibiotics."},{"key":"B66","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/sj.embor.embor748","article-title":"The big and small of drug discovery. Biotech versus pharma: advantages and drawbacks in drug development","volume":"4","author":"Moore","year":"2003","journal-title":"EMBO Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0014-5793(01)02648-5","article-title":"Optimization of the antimicrobial activity of magainin peptides by modification of charge","volume":"501","author":"Dathe","year":"2001","journal-title":"FEBS Lett."},{"key":"B68","doi-asserted-by":"publisher","first-page":"12426","DOI":"10.1021\/ja305644e","article-title":"Ab initio design of potent anti-MRSA peptides based on database filtering technology","volume":"134","author":"Mishra","year":"2012","journal-title":"J Am Chem Soc."},{"key":"B69","doi-asserted-by":"publisher","first-page":"13517","DOI":"10.1073\/pnas.1821410116","article-title":"Low cationicity is important for systemic in vivo efficacy of database-derived peptides against drug-resistant Gram-positive pathogens","volume":"116","author":"Mishra","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.4049\/jimmunol.169.7.3883","article-title":"The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses","volume":"169","author":"Scott","year":"2002","journal-title":"J Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/43088","article-title":"A peptide antibiotic from human skin","volume":"387","author":"Harder","year":"1997","journal-title":"Nature."},{"key":"B72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0014-5793(95)00634-L","article-title":"hCAP-18, a cathelin\/pro-bactenecin-like protein of human neutrophil specific granules","volume":"368","author":"Cowland","year":"1995","journal-title":"FEBS Lett."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-5793(95)01050-O","article-title":"Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain","volume":"374","author":"Zanetti","year":"1995","journal-title":"FEBS Lett."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1128\/AAC.49.5.1727-1732.2005","article-title":"Immunomodulatory activities of small host defense peptides","volume":"49","author":"Bowdish","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","article-title":"LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells","volume":"192","author":"De","year":"2000","journal-title":"J Exp Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.peptides.2011.06.005","article-title":"Wound healing activity of the human antimicrobial peptide LL37","volume":"32","author":"Ramos","year":"2011","journal-title":"Peptides."},{"key":"B77","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-981-13-3588-4_12","article-title":"Design of antimicrobial peptides: progress made with human cathelicidin LL-37","volume":"1117","author":"Wang","year":"2019","journal-title":"Adv Exp Med Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.bbamem.2014.01.016","article-title":"High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments","volume":"1838","author":"Wang","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B79","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/138920308783565714","article-title":"NMR of membrane-associated peptides and proteins","volume":"9","author":"Wang","year":"2008","journal-title":"Curr Protein Pept Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"32637","DOI":"10.1074\/jbc.M805533200","article-title":"Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles","volume":"283","author":"Wang","year":"2008","journal-title":"J Biol Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fmicb.2017.00544","article-title":"The naturally occurring host defense peptide, LL-37, and its truncated mimetics KE-18 and KR-12 have selected biocidal and antibiofilm activities against candida albicans, Staphylococcus aureus, and Escherichia coli in vitro","volume":"8","author":"Luo","year":"2017","journal-title":"Front Microbiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/psc.2552","article-title":"Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity","volume":"19","author":"Jacob","year":"2013","journal-title":"J Pept Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ejmech.2017.05.028","article-title":"LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity","volume":"136","author":"Kim","year":"2017","journal-title":"Eur J Med Chem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fphar.2019.00639","article-title":"KR-12-a5 reverses adverse effects of lipopolysaccharides on HBMSC osteogenic differentiation by influencing BMP\/Smad and P38 MAPK signaling pathways","volume":"10","author":"Li","year":"2019","journal-title":"Front Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3892\/mmr.2019.10843","article-title":"KR12a6 promotes the osteogenic differentiation of human bone marrow mesenchymal stem cells via BMP\/SMAD signaling","volume":"21","author":"Fu","year":"2020","journal-title":"Mol Med Rep."},{"key":"B86","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1021\/bi2016266","article-title":"Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins","volume":"51","author":"Wang","year":"2012","journal-title":"Biochemistry."},{"key":"B87","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/08927014.2017.1332186","article-title":"Titanium surfaces immobilized with the major antimicrobial fragment FK-16 of human cathelicidin LL-37 are potent against multiple antibiotic-resistant bacteria","volume":"33","author":"Mishra","year":"2017","journal-title":"Biofouling."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3389\/fmicb.2019.02190","article-title":"Cathelicidin-derived synthetic peptide improves therapeutic potential of vancomycin against Pseudomonas aeruginosa","volume":"10","author":"Mohammed","year":"2019","journal-title":"Front Microbiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.bbamem.2019.07.012","article-title":"Modulation of antimicrobial potency of human cathelicidin peptides against the ESKAPE pathogens and in vivo efficacy in a murine catheter-associated biofilm model","volume":"1861","author":"Narayana","year":"2019","journal-title":"Biochim Biophys Acta Biomembr."},{"key":"B90","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.peptides.2005.09.016","article-title":"Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application","volume":"27","author":"Nell","year":"2006","journal-title":"Peptides."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/j.bbamem.2015.07.010","article-title":"Phospholipid-driven differences determine the action of the synthetic antimicrobial peptide OP-145 on Gram-positive bacterial and mammalian membrane model systems","volume":"1848","author":"Malanovic","year":"2015","journal-title":"Biochim Biophys Acta."},{"key":"B92","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fchem.2017.00063","article-title":"Antimicrobial peptides in biomedical device manufacturing","volume":"5","author":"Riool","year":"2017","journal-title":"Front Chem."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1021\/acschembio.6b00843","article-title":"Host cell interactions are a significant barrier to the clinical utility of peptide antibiotics","volume":"11","author":"Starr","year":"2016","journal-title":"ACS Chem Biol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1021\/jm0703542","article-title":"Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect","volume":"50","author":"Svenson","year":"2007","journal-title":"J Med Chem."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.bbamem.2017.09.008","article-title":"Antimicrobial peptides are degraded by the cytosolic proteases of human erythrocytes","volume":"1859","author":"Starr","year":"2017","journal-title":"Biochim Biophys Acta Biomembr."},{"key":"B96","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1128\/AAC.48.12.4673-4679.2004","article-title":"Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases","volume":"48","author":"Sieprawska-Lupa","year":"2004","journal-title":"Antimicrob Agents Chemother."},{"key":"B97","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4236\/abb.2011.26059","article-title":"Degradation of naturally occurring and engineered antimicrobial peptides by proteases","volume":"2","author":"Moncla","year":"2011","journal-title":"Adv Biosci Biotechnol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e0178943","DOI":"10.1371\/journal.pone.0178943","article-title":"Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum","volume":"12","author":"Bottger","year":"2017","journal-title":"PLoS ONE."},{"key":"B99","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tibtech.2011.05.001","article-title":"The expanding scope of antimicrobial peptide structures and their modes of action","volume":"29","author":"Nguyen","year":"2011","journal-title":"Trends Biotechnol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.1167\/iovs.17-22243","article-title":"Designed host defense peptides for the treatment of bacterial keratitis","volume":"58","author":"Clemens","year":"2017","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/biom8020019","article-title":"Improving the activity of Trp-rich antimicrobial peptides by Arg\/Lys substitutions and changing the length of cationic residues","volume":"8","author":"Arias","year":"2018","journal-title":"Biomolecules."},{"key":"B102","doi-asserted-by":"publisher","first-page":"8888","DOI":"10.1038\/s41598-018-27231-5","article-title":"Exploring the role of unnatural amino acids in antimicrobial peptides","volume":"8","author":"Oliva","year":"2018","journal-title":"Sci Rep."},{"key":"B103","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1021\/jm061489v","article-title":"De novo design of selective antibiotic peptides by incorporation of unnatural amino acids","volume":"50","author":"Hicks","year":"2007","journal-title":"J Med Chem."},{"key":"B104","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.drudis.2016.11.003","article-title":"Peptidomimetic therapeutics: scientific approaches and opportunities","volume":"22","author":"Qvit","year":"2017","journal-title":"Drug Discov Today."},{"key":"B105","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.HYP.37.2.342","article-title":"Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure","volume":"37","author":"Gavras","year":"2001","journal-title":"Hypertension."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.4155\/fmc.12.108","article-title":"Exploring bioactive peptides from natural sources for oxytocin and vasopressin drug discovery","volume":"4","author":"Gruber","year":"2012","journal-title":"Future Med Chem."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3389\/fmicb.2017.02409","article-title":"Combination strategies to enhance the efficacy of antimicrobial peptides against bacterial biofilms","volume":"8","author":"Grassi","year":"2017","journal-title":"Front Microbiol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1128\/AAC.45.5.1558-1560.2001","article-title":"Synergistic interactions between mammalian antimicrobial defense peptides","volume":"45","author":"Yan","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"key":"B109","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2147\/IDR.S166236","article-title":"Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides","volume":"11","author":"Almaaytah","year":"2018","journal-title":"Infect Drug Resist."},{"key":"B110","doi-asserted-by":"publisher","first-page":"182980","DOI":"10.1016\/j.bbamem.2019.05.002","article-title":"Hybrids made from antimicrobial peptides with different mechanisms of action show enhanced membrane permeabilization","volume":"1861","author":"Wade","year":"2019","journal-title":"Biochim Biophys Acta Biomembr."},{"key":"B111","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11596-019-2042-2","article-title":"Rational design of hybrid peptides: a novel drug design approach","volume":"39","author":"Wang","year":"2019","journal-title":"Curr Med Sci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0014-5793(89)81505-4","article-title":"Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids","volume":"259","author":"Boman","year":"1989","journal-title":"FEBS Lett."},{"key":"B113","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0014-5793(92)80377-S","article-title":"Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity","volume":"296","author":"Andreu","year":"1992","journal-title":"FEBS Lett."},{"key":"B114","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1399-3011.1992.tb00321.x","article-title":"Antibacterial peptides designed as analogs or hybrids of cecropins and melittin","volume":"40","author":"Wade","year":"1992","journal-title":"Int J Pept Protein Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1399-3011.1999.tb01620.x","article-title":"Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides","volume":"53","author":"Shin","year":"1999","journal-title":"J Pept Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/AAC.01998-15","article-title":"Antimicrobial peptide CMA3 derived from the CA-MA hybrid peptide: antibacterial and anti-inflammatory activities with low cytotoxicity and mechanism of action in Escherichia coli","volume":"60","author":"Lee","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"B117","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/ijms17070983","article-title":"Novel hybrid peptide cecropin A (1-8)-LL37 (17-30) with potential antibacterial activity","volume":"17","author":"Wei","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1007\/s11033-013-2900-0","article-title":"Design, characterization and expression of a novel hybrid peptides melittin (1-13)-LL37 (17-30)","volume":"41","author":"Wu","year":"2014","journal-title":"Mol Biol Rep."},{"key":"B119","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2174\/1381612826666200128090700","article-title":"Functional characterization of a novel hybrid peptide with high potency against gram-negative bacteria","volume":"26","author":"Tall","year":"2020","journal-title":"Curr Pharm Des."},{"key":"B120","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2012.01.013","article-title":"Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II","volume":"33","author":"Fox","year":"2012","journal-title":"Peptides."},{"key":"B121","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1167\/iovs.16-19882","article-title":"Melimine-coated antimicrobial contact lenses reduce microbial keratitis in an animal model","volume":"57","author":"Dutta","year":"2016","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"111814","DOI":"10.1016\/j.ejmech.2019.111814","article-title":"Development of a novel hybrid antimicrobial peptide for targeted killing of Pseudomonas aeruginosa","volume":"185","author":"Kim","year":"2020","journal-title":"Eur J Med Chem."},{"key":"B123","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/s41598-020-58014-6","article-title":"Conversion of broad-spectrum antimicrobial peptides into species-specific antimicrobials capable of precisely targeting pathogenic bacteria","volume":"10","author":"Xu","year":"2020","journal-title":"Sci Rep."},{"key":"B124","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1128\/AAC.00622-06","article-title":"Targeted killing of Streptococcus mutans by a pheromone-guided \u201csmart\u201d antimicrobial peptide","volume":"50","author":"Eckert","year":"2006","journal-title":"Antimicrob Agents Chemother."},{"key":"B125","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.peptides.2016.05.010","article-title":"Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide","volume":"82","author":"Kim","year":"2016","journal-title":"Peptides."},{"key":"B126","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3389\/fmicb.2018.00683","article-title":"New insights into the mechanisms and biological roles of D-Amino acids in complex eco-systems","volume":"9","author":"Aliashkevich","year":"2018","journal-title":"Front Microbiol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3390\/ijms17071023","article-title":"Roles of d-amino acids on the bioactivity of host defense peptides","volume":"17","author":"Li","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1073\/pnas.87.12.4761","article-title":"All-D amino acid-containing channel-forming antibiotic peptides","volume":"87","author":"Wade","year":"1990","journal-title":"Proc Natl Acad Sci USA."},{"key":"B129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-08-100736-5.00005-3","article-title":"Peptides containing d-amino acids and retro-inverso peptides: general applications and special focus on antimicrobial peptides","volume-title":"Peptide Applications in Biomedicine, Biotechnology and Bioengineering","author":"Cardoso","year":"2018"},{"key":"B130","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s10930-013-9505-2","article-title":"Improved protease stability of the antimicrobial peptide Pin2 substituted with D-amino acids","volume":"32","author":"Carmona","year":"2013","journal-title":"Protein J."},{"key":"B131","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/abbs\/gmx091","article-title":"D-amino acid substitution enhances the stability of antimicrobial peptide polybia-CP","volume":"49","author":"Jia","year":"2017","journal-title":"Acta Biochim Biophys Sin."},{"key":"B132","doi-asserted-by":"publisher","first-page":"43384","DOI":"10.1038\/srep43384","article-title":"D-form KLKLLLLLKLK-NH2 peptide exerts higher antimicrobial properties than its L-form counterpart via an association with bacterial cell wall components","volume":"7","author":"Manabe","year":"2017","journal-title":"Sci Rep."},{"key":"B133","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1021\/bi052150y","article-title":"Effect of natural L- to D-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H","volume":"45","author":"Mangoni","year":"2006","journal-title":"Biochemistry."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkx349","article-title":"Daptomycin","volume":"73","author":"Heidary","year":"2018","journal-title":"J Antimicrob Chemother."},{"key":"B135","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/md16090305","article-title":"Toward the synthesis and improved biopotential of an N-methylated analog of a proline-rich cyclic tetrapeptide from marine bacteria","volume":"16","author":"Dahiya","year":"2018","journal-title":"Mar Drugs."},{"key":"B137","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/2211550111201010072","article-title":"Post-translational modifications of natural antimicrobial peptides and strategies for peptide engineering","volume":"1","author":"Wang","year":"2012","journal-title":"Curr Biotechnol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0116-z","article-title":"Spotlight on protein N-terminal acetylation","volume":"50","author":"Ree","year":"2018","journal-title":"Exp Mol Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"42994","DOI":"10.1038\/srep42994","article-title":"Highly potent antimicrobial peptides from N-terminal membrane-binding region of E. coli MreB","volume":"7","author":"Saikia","year":"2017","journal-title":"Sci Rep."},{"key":"B140","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/bip.21454","article-title":"Influence of N-terminus modifications on the biological activity, membrane interaction, and secondary structure of the antimicrobial peptide hylin-a1","volume":"96","author":"Crusca","year":"2011","journal-title":"Biopolymers."},{"key":"B141","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00249-015-1094-x","article-title":"The effect of amidation on the behaviour of antimicrobial peptides","volume":"45","author":"Mura","year":"2016","journal-title":"Eur Biophys J."},{"key":"B142","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1016\/j.bbamem.2012.07.026","article-title":"Binding and reorientation of melittin in a POPC bilayer: computer simulations","volume":"1818","author":"Irudayam","year":"2012","journal-title":"Biochim Biophys Acta."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1021\/bi101687t","article-title":"Influence of C-terminal amidation on the efficacy of modelin-5","volume":"50","author":"Dennison","year":"2011","journal-title":"Biochemistry."},{"key":"B144","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/psc.960","article-title":"Study of the mechanism of action of anoplin, a helical antimicrobial decapeptide with ion channel-like activity, and the role of the amidated C-terminus","volume":"14","author":"Dos Santos Cabrera","year":"2008","journal-title":"J Pept Sci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/psc.1148","article-title":"Esculentin 1-21: a linear antimicrobial peptide from frog skin with inhibitory effect on bovine mastitis-causing bacteria","volume":"15","author":"Islas-Rodriguez","year":"2009","journal-title":"J Pept Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s10517-017-3705-2","article-title":"Effect of N- and C-terminal modifications on cytotoxic properties of antimicrobial peptide tachyplesin I","volume":"162","author":"Kuzmin","year":"2017","journal-title":"Bull Exp Biol Med."},{"key":"B147","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10989-016-9555-3","article-title":"Peptides with 6-aminohexanoic acid: synthesis and evaluation as plasmin inhibitors","volume":"23","author":"Purwin","year":"2017","journal-title":"Int J Pept Res Ther."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00726-014-1686-2","article-title":"Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase","volume":"46","author":"Falciani","year":"2014","journal-title":"Amino Acids."},{"key":"B149","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cbpa.2017.02.006","article-title":"Cyclic peptide therapeutics: past, present and future","volume":"38","author":"Zorzi","year":"2017","journal-title":"Curr Opin Chem Biol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis."},{"key":"B151","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1128\/CMR.3.3.280","article-title":"Resistance to vancomycin and teicoplanin: an emerging clinical problem","volume":"3","author":"Johnson","year":"1990","journal-title":"Clin Microbiol Rev."},{"key":"B152","doi-asserted-by":"publisher","first-page":"9140","DOI":"10.1021\/bi035948v","article-title":"Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides","volume":"43","author":"Dathe","year":"2004","journal-title":"Biochemistry."},{"key":"B153","doi-asserted-by":"publisher","first-page":"14242","DOI":"10.1002\/chem.201802881","article-title":"Arginine\/tryptophan-rich cyclic \u03b1\/\u03b2-antimicrobial peptides: the roles of hydrogen bonding and hydrophobic\/hydrophilic solvent-accessible surface areas upon activity and membrane selectivity","volume":"24","author":"Bagheri","year":"2018","journal-title":"Chemistry."},{"key":"B154","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/35086601","article-title":"Antibacterial agents based on the cyclic D,L-alpha-peptide architecture","volume":"412","author":"Fernandez-Lopez","year":"2001","journal-title":"Nature."},{"key":"B155","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1128\/AAC.49.8.3302-3310.2005","article-title":"Systemic antibacterial activity of novel synthetic cyclic peptides","volume":"49","author":"Dartois","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.bbamem.2011.05.001","article-title":"Structural basis for the enhanced activity of cyclic antimicrobial peptides: the case of BPC194","volume":"1808","author":"Mika","year":"2011","journal-title":"Biochim Biophys Acta."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3390\/molecules22071217","article-title":"Cyclic peptides as novel therapeutic microbicides: engineering of human defensin mimetics","volume":"22","author":"Falanga","year":"2017","journal-title":"Molecules."},{"key":"B158","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.coi.2007.06.008","article-title":"Defensins in the immunology of bacterial infections","volume":"19","author":"Menendez","year":"2007","journal-title":"Curr Opin Immunol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s13205-019-1725-5","article-title":"Plant defensins: types, mechanism of action and prospects of genetic engineering for enhanced disease resistance in plants","volume":"9","author":"Sher Khan","year":"2019","journal-title":"3 Biotech"},{"key":"B160","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.2147\/IJN.S89610","article-title":"Design and activity of a cyclic mini-beta-defensin analog: a novel antimicrobial tool","volume":"10","author":"Scudiero","year":"2015","journal-title":"Int J Nanomedicine."},{"key":"B161","doi-asserted-by":"publisher","first-page":"26516","DOI":"10.1073\/pnas.1909585117","article-title":"The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection","volume":"116","author":"Mwangi","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B162","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/molecules25010112","article-title":"The history of nanoscience and nanotechnology: from chemical-physical applications to nanomedicine","volume":"25","author":"Bayda","year":"2019","journal-title":"Molecules."},{"key":"B163","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","article-title":"Nanoparticles: properties, applications and toxicities","volume":"12","author":"Khan","year":"2019","journal-title":"Arab J Chemistry."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2174\/1389200218666170925122201","article-title":"Engineered nanoparticles with antimicrobial property","volume":"18","author":"Reshma","year":"2017","journal-title":"Curr Drug Metab."},{"key":"B165","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/femsre\/fux003","article-title":"From nano to micro: using nanotechnology to combat microorganisms and their multidrug resistance","volume":"41","author":"Natan","year":"2017","journal-title":"FEMS Microbiol Rev."},{"key":"B166","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3389\/fmicb.2018.00855","article-title":"Antimicrobial peptides and nanotechnology, recent advances and challenges","volume":"9","author":"Biswaro","year":"2018","journal-title":"Front Microbiol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"e1701400","DOI":"10.1002\/adhm.201701400","article-title":"Recent advances in the development of antimicrobial nanoparticles for combating resistant pathogens","volume":"7","author":"Lakshminarayanan","year":"2018","journal-title":"Adv Healthc Mater."},{"key":"B168","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnology."},{"key":"B169","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2014.08.016","article-title":"PLGA nanoparticles loaded with host defense peptide LL37 promote wound healing","volume":"194","author":"Chereddy","year":"2014","journal-title":"J Control Release."},{"key":"B170","doi-asserted-by":"publisher","first-page":"8359","DOI":"10.1021\/acs.jpcb.8b05717","article-title":"Atomistic-level investigation of a LL37-conjugated gold nanoparticle by well-tempered metadynamics","volume":"122","author":"Ferreira","year":"2018","journal-title":"J Phys Chem B."},{"key":"B171","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jconrel.2017.07.007","article-title":"Antimicrobial peptide-gold nanoscale therapeutic formulation with high skin regenerative potential","volume":"262","author":"Comune","year":"2017","journal-title":"J Control Release."},{"key":"B172","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12951-019-0566-z","article-title":"Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications","volume":"18","author":"Wnorowska","year":"2020","journal-title":"J Nanobiotechnol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly Lactic-co-Glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers."},{"key":"B174","doi-asserted-by":"publisher","first-page":"135102","DOI":"10.1088\/1361-6528\/aa5f63","article-title":"Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA)","volume":"28","author":"Cruz","year":"2017","journal-title":"Nanotechnology."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1039\/C1NR11188D","article-title":"Gold nanoparticles: preparation, properties, and applications in bionanotechnology","volume":"4","author":"Yeh","year":"2012","journal-title":"Nanoscale."},{"key":"B176","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.actbio.2016.09.041","article-title":"Gold-nanoparticles coated with the antimicrobial peptide esculentin-1a(1-21)NH2 as a reliable strategy for antipseudomonal drugs","volume":"47","author":"Casciaro","year":"2017","journal-title":"Acta Biomater."},{"key":"B177","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.metabol.2017.01.011","article-title":"Artificial intelligence in medicine","author":"Hamet","year":"2017","journal-title":"Metabolism."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1136\/bjophthalmol-2019-315025","article-title":"Artificial intelligence-assisted telemedicine platform for cataract screening and management: a potential model of care for global eye health","volume":"103","author":"Ting","year":"2019","journal-title":"Br J Ophthalmol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41573-019-0050-3","article-title":"Rethinking drug design in the artificial intelligence era","volume":"19","author":"Schneider","year":"2019","journal-title":"Nat Rev Drug Discov."},{"key":"B180","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature."},{"key":"B181","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.3389\/fmicb.2019.03097","article-title":"Computer-aided design of antimicrobial peptides: are we generating effective drug candidates?","volume":"10","author":"Cardoso","year":"2019","journal-title":"Front Microbiol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1021\/cb800240j","article-title":"Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs","volume":"4","author":"Cherkasov","year":"2009","journal-title":"ACS Chem Biol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"13588","DOI":"10.1073\/pnas.1609893113","article-title":"Mapping membrane activity in undiscovered peptide sequence space using machine learning","volume":"113","author":"Lee","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B184","doi-asserted-by":"publisher","first-page":"6944","DOI":"10.1073\/pnas.1819250116","article-title":"Unifying structural signature of eukaryotic alpha-helical host defense peptides","volume":"116","author":"Yount","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B185","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ab.2013.01.019","article-title":"iAMP-2L: a two-level multi-label classifier for identifying antimicrobial peptides and their functional types","volume":"436","author":"Xiao","year":"2013","journal-title":"Anal Biochem."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1126\/science.1217405","article-title":"Evolutionary trade-offs, pareto optimality, and the geometry of phenotype space","volume":"336","author":"Shoval","year":"2012","journal-title":"Science."},{"key":"B187","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nbt.2572","article-title":"Antimicrobial peptides stage a comeback","volume":"31","author":"Fox","year":"2013","journal-title":"Nat Biotechnol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1086\/593185","article-title":"Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream","volume":"47","author":"Lipsky","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B189","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/nbt1113","article-title":"High-throughput generation of small antibacterial peptides with improved activity","volume":"23","author":"Hilpert","year":"2005","journal-title":"Nat Biotechnol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"29707","DOI":"10.1038\/srep29707","article-title":"Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus","volume":"6","author":"Mohamed","year":"2016","journal-title":"Sci Rep."},{"key":"B191","first-page":"243","article-title":"The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis","volume":"100","author":"Mannis","year":"2002","journal-title":"Trans Am Ophthalmol Soc."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3389\/fmicb.2019.01703","article-title":"Combinatory therapy antimicrobial peptide-antibiotic to minimize the ongoing rise of resistance","volume":"10","author":"Pizzolato-Cezar","year":"2019","journal-title":"Front Microbiol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"25905","DOI":"10.1038\/srep25905","article-title":"Branched peptide, B2088, disrupts the supramolecular organization of lipopolysaccharides and sensitizes the gram-negative bacteria","volume":"6","author":"Lakshminarayanan","year":"2016","journal-title":"Sci Rep."},{"key":"B194","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s12602-018-9465-0","article-title":"Antimicrobial peptides: the achilles' heel of antibiotic resistance?","volume":"11","author":"Lewies","year":"2019","journal-title":"Probiotics Antimicrob Proteins."},{"key":"B195","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1089\/mdr.2017.0392","article-title":"Antimicrobial peptides: features, action, and their resistance mechanisms in bacteria","volume":"24","author":"Moravej","year":"2018","journal-title":"Microb Drug Resist."},{"key":"B196","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1038\/s41467-019-12364-6","article-title":"Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance","volume":"10","author":"Spohn","year":"2019","journal-title":"Nat Commun."},{"key":"B197","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1038\/s41467-019-13618-z","article-title":"Chemical-genetic profiling reveals limited cross-resistance between antimicrobial peptides with different modes of action","volume":"10","author":"Kintses","year":"2019","journal-title":"Nat Commun."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00983\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T04:46:34Z","timestamp":1590122794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00983\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":197,"alternative-id":["10.3389\/fimmu.2020.00983"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00983","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]},"article-number":"983"}}